0.7444
                                            
            Assertio Holdings Inc stock is traded at $0.7444, with a volume of 244.49K.
            It is down -1.01% in the last 24 hours and down -15.49% over the past month.
            Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
        
        See More
    Previous Close:
              $0.752
            Open:
              $0.7402
            24h Volume:
                244.49K
            Relative Volume:
              0.95
            Market Cap:
                $71.64M
            Revenue:
              $169.43M
            Net Income/Loss:
              $-186.01M
            P/E Ratio:
              -0.3685
            EPS:
                -2.02
            Net Cash Flow:
                $70.07M
            1W Performance:
              -9.23%
            1M Performance:
              -15.49%
            6M Performance:
                +14.59%
            1Y Performance:
              -27.73%
            Assertio Holdings Inc Stock (ASRT) Company Profile
Name
                  
                      Assertio Holdings Inc
                    
                Sector
                  Phone
                  
                      (224) 419-7106
                    
                Address
                  
                      100 S. SAUNDERS ROAD, LAKE FOREST, IL
                    
                Compare ASRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                ASRT
                            
                             Assertio Holdings Inc | 0.7444 | 72.37M | 169.43M | -186.01M | 70.07M | -2.02 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy | 
| Jul-03-24 | Initiated | H.C. Wainwright | Buy | 
| Nov-07-22 | Initiated | Lake Street | Buy | 
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral | 
Assertio Holdings Inc Stock (ASRT) Latest News
Will Assertio Holdings Inc. stock sustain high P E ratiosJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
Why Assertio Holdings Inc. stock appeals to dividend seekersGold Moves & Real-Time Chart Breakout Alerts - newser.com
Intraday pattern recognizer results for Assertio Holdings Inc.July 2025 Breakouts & Verified Chart Pattern Signals - newser.com
How Assertio Holdings Inc. stock compares to market leadersWeekly Trade Recap & High Accuracy Trade Alerts - newser.com
Can Assertio Holdings Inc. recover in the next quarterWatch List & AI Driven Stock Price Forecasts - newser.com
Key metrics from Assertio Holdings Inc.’s quarterly data2025 Earnings Surprises & Long-Term Investment Growth Plans - newser.com
Using R and stats models for Assertio Holdings Inc. forecasting2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - newser.com
Applying Elliott Wave Theory to Assertio Holdings Inc.2025 Retail Activity & AI Forecasted Stock Moves - newser.com
Will Assertio Holdings Inc. stock benefit from AI adoptionShort Setup & Smart Swing Trading Alerts - newser.com
Using AI based signals to follow Assertio Holdings Inc.July 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
Why Assertio Holdings Inc. stock is seen as undervaluedJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
What does recent volatility data suggest for Assertio Holdings Inc.2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
Using Ichimoku Cloud for Assertio Holdings Inc. technicals2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
How to manage a losing position in Assertio Holdings Inc.July 2025 Review & Target Return Focused Picks - newser.com
Is Assertio Holdings Inc. stock oversold or undervaluedWeekly Risk Summary & Safe Entry Momentum Stock Tips - newser.com
Assertio names Mark Reisenauer as new CEO, effective immediately - Investing.com
Assertio Announces Leadership Transition - The Manila Times
Assertio (Nasdaq: ASRT) sets Q3 results Nov. 10; expects guidance update within the current range - Stock Titan
How Assertio Holdings Inc. stock reacts to global recession fearsEarnings Risk Summary & Weekly Breakout Watchlists - Fundação Cultural do Pará
Will Assertio Holdings Inc. stock benefit from infrastructure spendingJuly 2025 Closing Moves & Low Risk High Reward Trade Ideas - Fundação Cultural do Pará
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assertio Holdings Inc Stock (ASRT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | 
|---|---|---|---|---|---|---|---|
| Schlessinger Sam | EVP, General Counsel | May 12 '25 | Option Exercise | 0.00 | 38,017 | 0 | 191,906 | 
| Schwichtenberg Paul | See Remarks | May 12 '25 | Option Exercise | 0.00 | 38,017 | 0 | 184,362 | 
| Patel Ajay | EVP and CFO | May 12 '25 | Option Exercise | 0.00 | 38,017 | 0 | 213,692 | 
| Schlessinger Sam | SVP, General Counsel | Feb 21 '25 | Option Exercise | 0.00 | 17,150 | 0 | 161,545 | 
| Schwichtenberg Paul | See Remarks | Feb 21 '25 | Option Exercise | 0.00 | 17,150 | 0 | 154,850 | 
| Patel Ajay | SVP and CFO | Feb 21 '25 | Option Exercise | 0.00 | 17,150 | 0 | 184,180 | 
| Schlessinger Sam | SVP, General Counsel | Feb 07 '25 | Option Exercise | 0.00 | 21 | 0 | 153,698 | 
| Schwichtenberg Paul | See Remarks | Feb 07 '25 | Option Exercise | 0.00 | 25,000 | 0 | 150,101 | 
| Patel Ajay | SVP and CFO | Feb 07 '25 | Option Exercise | 0.00 | 25,000 | 0 | 179,431 | 
| Mason Heather L | Director | Nov 18 '24 | Buy | 0.80 | 75,000 | 60,000 | 287,650 | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App